Bruker Corp (BRKR)
76.70
-1.59
(-2.03%)
USD |
NASDAQ |
May 23, 16:00
76.71
+0.01
(+0.01%)
After-Hours: 20:00
Bruker Research and Development Expense (Quarterly): 81.80M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 81.80M |
December 31, 2023 | 83.50M |
September 30, 2023 | 71.30M |
June 30, 2023 | 71.00M |
March 31, 2023 | 69.00M |
December 31, 2022 | 63.50M |
September 30, 2022 | 56.20M |
June 30, 2022 | 59.60M |
March 31, 2022 | 56.60M |
December 31, 2021 | 58.10M |
September 30, 2021 | 52.10M |
June 30, 2021 | 55.80M |
March 31, 2021 | 54.80M |
December 31, 2020 | 57.10M |
September 30, 2020 | 48.30M |
June 30, 2020 | 44.10M |
March 31, 2020 | 48.50M |
December 31, 2019 | 46.70M |
September 30, 2019 | 46.10M |
June 30, 2019 | 48.50M |
March 31, 2019 | 46.40M |
December 31, 2018 | 44.80M |
September 30, 2018 | 41.80M |
June 30, 2018 | 43.60M |
March 31, 2018 | 43.20M |
Date | Value |
---|---|
December 31, 2017 | 43.10M |
September 30, 2017 | 40.60M |
June 30, 2017 | 40.30M |
March 31, 2017 | 37.60M |
December 31, 2016 | 37.10M |
September 30, 2016 | 37.90M |
June 30, 2016 | 36.80M |
March 31, 2016 | 36.10M |
December 31, 2015 | 36.70M |
September 30, 2015 | 34.30M |
June 30, 2015 | 37.50M |
March 31, 2015 | 37.20M |
December 31, 2014 | 41.60M |
September 30, 2014 | 42.10M |
June 30, 2014 | 44.50M |
March 31, 2014 | 46.00M |
December 31, 2013 | 49.10M |
September 30, 2013 | 45.50M |
June 30, 2013 | 46.50M |
March 31, 2013 | 49.40M |
December 31, 2012 | 50.30M |
September 30, 2012 | 44.90M |
June 30, 2012 | 51.90M |
March 31, 2012 | 48.20M |
December 31, 2011 | 44.70M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
44.10M
Minimum
Jun 2020
83.50M
Maximum
Dec 2023
58.63M
Average
56.40M
Median
Research and Development Expense (Quarterly) Benchmarks
Cardinal Health Inc | -- |
Accelerate Diagnostics Inc | 5.173M |
NanoString Technologies Inc | 17.12M |
AIM ImmunoTech Inc | 1.951M |
NovaBay Pharmaceuticals Inc | 0.019M |